產品描述: DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9. |
靶點:
DPP-4;Proteasome;Proteasome;?DPP-4 |
體外研究:
DBPR108 displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. |
體內研究:
DBPR108 is a potent, selective, long-acting and safe DPP-IV inhibitor as a potential treatment of type 2 diabetes mellitus. The in vivo effects of DBPR108, including inhibition of plasma DPP-IV activity and suppression of blood glucose elevation, were also demonstrated. |
參考文獻:
1. Yeh TK, et al. (2S,4S)-1-[2-(1,1-dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV. Bioorg Med Chem Lett. 2010 Jun |
溶解性:
soluble in DMSO |
保存條件:
-20℃ |
配置溶液濃度參考:
|
1mg |
5mg |
10mg |
1 mM |
3.083 ml |
15.413 ml |
30.827 ml |
5 mM |
0.617 ml |
3.083 ml |
6.165 ml |
10 mM |
0.308 ml |
1.541 ml |
3.083 ml |
50 mM |
0.062 ml |
0.308 ml |
0.617 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |